Ignite Creation Date:
2025-12-24 @ 4:42 PM
Ignite Modification Date:
2025-12-24 @ 4:42 PM
Study NCT ID:
NCT03929666
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2019-02-22
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-22
First Submit QC Date:
None
Study First Post Date:
2019-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-10
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED